Stevanato Group S.p.A (STVN) Current Deferred Revenue (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Current Deferred Revenue of $13.6 million for Q1 2026, up 12.93% year-over-year from $12.0 million in Q1 2025, and up 12.02% quarter-over-quarter from $12.1 million in Q4 2025.
Stevanato Group S.p.A (STVN) Current Deferred Revenue (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Current Deferred Revenue for 7 consecutive years, with $13.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Deferred Revenue rose 12.93% year-over-year to $13.6 million; the TTM figure through Mar 2026 stood at $13.6 million (up 12.93% YoY), while the FY2025 annual figure was $12.1 million, up 168.75% from the prior year.
- Current Deferred Revenue rose to $13.6 million in Q1 2026 per STVN's latest filing, from $12.1 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $28.0 million in Q1 2024 and bottomed at -$24.0 million in Q4 2023.
- Historically, Current Deferred Revenue has averaged $10.6 million across 5 years, with a median of $12.1 million in 2025.
- Annual changes were most pronounced in 2022 — Current Deferred Revenue soared 215.32% — and 2025, when it plunged 63.44%.
- Stevanato Group S.p.A's Current Deferred Revenue stood at -$15.1 million in 2022, then plunged by 58.9% to -$24.0 million in 2023, then increased by 26.51% to -$17.6 million in 2024, then soared by 168.75% to $12.1 million in 2025, then advanced by 12.02% to $13.6 million in 2026.
- Business Quant data shows STVN's Current Deferred Revenue at $13.6 million in Q1 2026, $12.1 million in Q4 2025, and $9.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.41 Mn |
| Mar 31, 2026 | 13.58 Mn |
| Dec 31, 2025 | 12.12 Mn |
| Sep 30, 2025 | 9.32 Mn |
| Jun 30, 2025 | 11.56 Mn |
| Mar 31, 2025 | 12.03 Mn |
| Dec 31, 2024 | -17.63 Mn |
| Sep 30, 2024 | 25.50 Mn |
| Jun 30, 2024 | 25.31 Mn |
| Mar 31, 2024 | 27.99 Mn |
| Dec 31, 2023 | -23.99 Mn |
| Sep 30, 2023 | 10.72 Mn |
| Jun 30, 2023 | 12.15 Mn |
| Mar 31, 2023 | 11.13 Mn |
| Dec 31, 2022 | -15.10 Mn |
| Sep 30, 2022 | 23.30 Mn |
| Jun 30, 2022 | 24.50 Mn |
| Mar 31, 2022 | 17.64 Mn |
| Dec 31, 2021 | -21.51 Mn |
| Sep 30, 2021 | 16.44 Mn |